Federal Decide Dan A. Polster, of the U.S. District Court docket’s Northern District of Ohio, poses in an undated photograph obtained by Reuters in Cleveland, Ohio, U.S. June 24, 2019. To match Particular Report USA-COURTS/SECRECY-JUDGES. Northern District of Ohio/Handout through REUTERS.
(Reuters) – A federal appeals court docket on Thursday rejected a bid by eight drug retailers and distributors to disqualify the decide overseeing nationwide opioid litigation, after they claimed his rulings, public statements and efforts to encourage settlements created an look of bias.
The ruling, by the sixth U.S. Circuit Court docket of Appeals in Cincinnati, means U.S. District Decide Dan Polster can proceed presiding over the litigation, together with a landmark trial scheduled to start in Cleveland on Oct. 21.
Corporations that sought Polster’s removing included retailers CVS Well being Corp, Ceremony Help Corp, Walgreens Boots Alliance Inc and Walmart Inc, and distributors AmerisourceBergen Corp, Cardinal Well being Inc, Henry Schein Inc and McKesson Corp.
Reporting by Jonathan Stempel in New York